文献速递姑息放疗与转移瘤胸部肿瘤放疗

美国弱势群体放射治疗可及性危机:美洲印第安患者

The pervasive crisis of diminishing radiation therapy access for vulnerable populations in the United States, part 2: American Indian patients.
PubMed 文献 · Adv Radiat Oncol · 2017-08-26

本文综述美国印第安/阿拉斯加原住民(AI/AN)癌症患者在放射治疗可及性方面的差异,通过检索PubMed仅发现3项研究,均来自Walking Forward项目;该项目通过患者导航、社区教育和临床试验入组覆盖超过4000例AI/AN患者,15年间使患者就诊时分期更早、治愈率更高;作者呼吁推广类似举措以缩小差距。

要点

  • AI/AN癌症患者就诊时分期更晚,癌症特异性生存率在所有种族/族裔中最低。
  • 关于AI/AN患者放疗可及性差异的文献极少,仅3项研究均来自Walking Forward项目。
  • Walking Forward项目15年间通过患者导航等覆盖超过4000例AI/AN患者,使患者分期更早、治愈率更高。

核心结论

  • 关于AI/AN患者放射治疗可及性的信息有限,几乎所有同行评议的进展均与Walking Forward项目相关。
  • 该项目15年间使患者就诊时分期更早、治愈率更高,作者希望其举措能在全国推广以减少障碍。

研究设计与样本

  • 本文为综述,检查了美国国家癌症研究所(NCI)针对AI/AN差异的举措,并进行了广泛的PubMed文献检索以寻找调查AI/AN患者放疗可及性差异的研究。

主要发现

  • 描述AI/AN患者放疗可及性差异的文献稀少,仅发现3项研究,均描述Walking Forward项目的举措。
  • Walking Forward项目针对北部平原地区AI人群癌症筛查障碍(如地理偏远和对医疗服务提供者的不信任),使用患者导航、社区教育和临床试验入组。
  • 该项目在15年间覆盖超过4000例AI/AN患者,使患者就诊时分期更早并经历更高的治愈率。
  • 肺癌是AI/AN患者癌症相关死亡最常见原因,是该项目的最近和持续焦点。

临床怎么用

  • 可借鉴Walking Forward项目的患者导航、社区教育和临床试验入组模式,以减少AI/AN患者放疗可及性障碍。
  • 鉴于与全球弱势人群癌症差异的相似性,应将AI/AN经验纳入全球癌症照护短缺的广泛议题。

局限性

  • 关于AI/AN患者放疗可及性的文献稀少,仅3项研究且均来自同一项目。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: American Indian/Alaska Native (AI/AN) patients with cancer disproportionally present with more advanced stages of disease and have the worst cancer-specific survival rates of any racial/ethnic group in the United States. The presence of disparities in radiation therapy (RT) access for AI/AN patients has rarely been examined. METHODS AND MATERIALS: National Cancer Institute (NCI) initiatives toward addressing AI/AN disparities were examined. Additionally, an extensive PubMed literature search for studies investigating RT access disparities in AI/AN patients was performed. RESULTS: Literature describing RT access disparities for the AI/AN patient population is sparse, revealing only 3 studies, each of which described initiatives from the Walking Forward program, the NCI Cancer Disparity Research Partnership initiative to address barriers to cancer screening among AI populations in the Northern Plains region (eg, geographic remoteness and mistrust of health care providers). This program has used patient navigation, community education, and access to clinical trials for more than 4000 AI/AN patients to combat high cancer mortality rates. Over the course of its 15-year existence, the program has resulted in patients presenting with earlier stages of disease and experiencing higher cure rates. Lung cancer, the most common cause of cancer-related mortality in AI/AN patients, is the most recent and ongoing focus of the program. CONCLUSION: The amount of information regarding RT access in AI/AN patients is limited, with nearly all peer-reviewed published progress in this area being associated with the Walking Forward program. Further initiatives from this program will hopefully inspire similar initiatives throughout the country to reduce the barriers to optimized cancer care that these patients face. Given the similarities with cancer disparities of populations worldwide, the AI/AN experience should be included within the broad issue of a global shortage of cancer care among underserved populations.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. McClelland S, Leberknight J, Guadagnolo BA, et al. The pervasive crisis of diminishing radiation therapy access for vulnerable populations in the United States, part 2: American Indian patients. Adv Radiat Oncol. 2017. PMID: 29556572. doi:10.1016/j.adro.2017.08.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。